Indoco Remedies
Indoco Remedies Ltd., a prominent player in the pharmaceutical industry, is headquartered in Mumbai, India. Established in 1945, the company has made significant strides in the development and manufacturing of a diverse range of pharmaceutical products, including formulations and active pharmaceutical ingredients (APIs). With a strong presence in both domestic and international markets, Indoco Remedies operates in various regions, focusing on key therapeutic areas such as anti-infectives, cardiovascular, and central nervous system disorders. Renowned for its commitment to quality and innovation, Indoco Remedies has achieved several milestones, including regulatory approvals from major global health authorities. The company’s core offerings are distinguished by their adherence to stringent quality standards and a robust research and development framework. As a result, Indoco Remedies has established a solid market position, recognised for its reliability and excellence in the pharmaceutical sector.
DitchCarbon Score
How does Indoco Remedies's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Indoco Remedies's score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Indoco Remedies's reported carbon emissions
In 2024, Indoco Remedies reported total carbon emissions of approximately 15,000,000 kg CO2e for Scope 1 and about 36,500,000 kg CO2e for Scope 2, resulting in a combined total of around 52,500,000 kg CO2e. This reflects a slight increase in emissions compared to 2023, where Scope 1 emissions were about 12,800,000 kg CO2e and Scope 2 emissions were approximately 44,500,000 kg CO2e, leading to a total of around 57,300,000 kg CO2e. The company has consistently disclosed emissions data for Scope 1 and Scope 2 but has not reported any Scope 3 emissions. Notably, there are no specific reduction targets or climate pledges documented, indicating a potential area for future commitment. Indoco Remedies' emissions intensity per rupee of turnover has shown a decrease from 0.000734 in 2023 to 0.000611 in 2024, suggesting improved efficiency in their operations. The data is sourced directly from Indoco Remedies Limited, with no cascading from a parent or related organization. Overall, while Indoco Remedies has made strides in emissions reporting and efficiency, the absence of formal reduction targets highlights an opportunity for enhanced climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 12,827,330 | 00,000,000 | 00,000,000 |
| Scope 2 | 44,543,700 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Indoco Remedies is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
